Discover 520 paid clinical trials in Madison, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 520
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes
for
Diabetes, Diabetes Type 2
Location: Madison WI
Sponsor: University of Wisconsin, Madison
Sex: All
Age: 18 - 70+
Code: NCT05912647
Recruiting
Treatment Study of AV Node Reentry Tachycardia
for
Supraventricular Tachycardia
Location: Madison WI, Iowa City IA, Louisville KY, Washington DC,
Sponsor: Jeffrey Moak
Sex: All
Age: 0 - 21
Code: NCT04232371
Recruiting
Lead-212 PSV359 Therapy for Patients With Solid Tumors
for
Pancreatic Ductal Adenocarcinoma, Gastric Cancer,
Location: Madison WI, Rochester MN, St Louis MO, Omaha NE,
Sponsor: Perspective Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06710756
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for
Ovarian Cancer
Location: Madison WI, Evanston IL, Grand Rapids MI,
Sponsor: Daiichi Sankyo
Sex: Female
Age: 18+
Code: NCT06819007
Phase 3, Recruiting
TRIAD Burden of Illness Mucositis Study
for
Gastrointestinal Mucositis (Defined as Mucositis Involving the Mouth, Esophagus, or Small Intestine),
Location: Madison WI
Sponsor: TRIAD Burden of Illness
Sex: All
Age: 18+
Code: NCT00336609
Recruiting
The Options 2 Study
for
Smoker, Smoking Cessation
Location: Madison WI
Sponsor: University of Wisconsin, Madison
Sex: All
Age: 21+
Code: NCT06595459
Recruiting
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
for
Locally Advanced Breast Cancer, Unresectable Breast Carcinoma,
Location: Madison WI, Chicago IL, Grand Rapids MI, St Louis MO,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06827236
Phase 1, Phase 2, Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for
Neoplasms
Location: Madison WI, Milwaukee WI, Chicago IL, Rochester MN,
Sponsor: Celgene
Sex: All
Age: 0+
Code: NCT03435796
Phase 2, Phase 3, Recruiting
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Location: Madison WI, Toronto, Winnipeg, Hershey PA,
Sponsor: Apollomics Inc.
Sex: All
Age: 18+
Code: NCT03175224
Phase 2, Recruiting
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
for
Locoregional Recurrence,
Location: Madison WI, Chicago IL, Iowa City IA, Fort Wayne IN,
Sponsor: Oana Danciu
Sex: All
Age: 18+
Code: NCT05467891
Phase 2, Recruiting
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
for
Cystic Fibrosis
Location: Madison WI, Chicago IL, Grand Rapids MI, Minneapolis MN,
Sponsor: Nicole Hamblett
Sex: All
Age: 12+
Code: NCT06504589
Recruiting
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
for
Non-small Cell Lung Cancer
Location: Madison WI, Skokie IL, Cincinnati OH, Kansas City MO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06345729
Phase 3, Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
for
Breast Neoplasms
Location: Madison WI, Cincinnati OH, Lexington KY, Nashville TN,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07060807
Phase 3, Recruiting
Prospective Registry to Evaluate Outcomes of NanoBone® Bone Graft in Acute Trauma
for
Fractures, Bone
Location: Madison WI
Sponsor: Artoss Inc.
Sex: All
Age: 18+
Code: NCT06256458
Recruiting
Effects of E-cigarette Use on Health
for
Electronic Cigarette Use
Location: Madison WI
Sponsor: University of Wisconsin, Madison
Sex: All
Age: 21+
Code: NCT06610838
Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Location: Madison WI, Milwaukee WI, Green Bay WI, Chicago IL,
Sponsor: Sameek Roychowdhury
Sex: All
Age: 18+
Code: NCT06906562
Phase 2, Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Madison WI, Iowa City IA, Grand Rapids MI,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136559
Phase 3, Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer